Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-04-01 | Dr. Nataliya AgafonovaChief Medical Officer | -13,15k | 14,72k | Sale to Issuer | 1,12 | 203,42k | -6,07% |
| 2026-04-01 | Ms. Lisa A. LocklearCFO, Exec. VP & Treasurer | -13,15k | 14,72k | Sale to Issuer | 1,12 | 215,69k | -5,74% |
| 2026-04-01 | Mr. Devin BlassCTO and Senior VP of Chemistry, Manufacturing & Controls | -8,63k | 9,67k | Sale to Issuer | 1,12 | 191,54k | -4,31% |
| 2026-04-01 | Mr. Stephen H. WillardCEO | -4,74k | 5,31k | Sale to Issuer | 1,12 | 289,73k | -1,61% |
| 2026-04-01 | Mr. Paul T. LehrGeneral Counsel & Secretary | -5,61k | 6,28k | Sale to Issuer | 1,12 | 338,57k | -1,63% |
| 2026-03-02 | Mr. Stephen H. WillardCEO | -105,53k | 57,52k | Sale to Issuer | 0,55 | 294,47k | -26,38% |
| 2026-01-02 | Mr. Than PowellInsider | -2,46k | 1,46k | Sale to Issuer | 0,59 | 125,59k | -1,92% |
| 2026-01-02 | Ms. Lisa A. LocklearCFO, Exec. VP & Treasurer | -10,25k | 6,08k | Sale to Issuer | 0,59 | 228,83k | -4,29% |
| 2026-01-02 | Mr. Paul T. LehrGeneral Counsel & Secretary | -6,95k | 4,12k | Sale to Issuer | 0,59 | 344,18k | -1,98% |
| 2026-01-02 | Mr. Devin BlassCTO and Senior VP of Chemistry, Manufacturing & Controls | -10,70k | 6,35k | Sale to Issuer | 0,59 | 200,18k | -5,07% |
| 2026-01-02 | Dr. Nataliya AgafonovaChief Medical Officer | -10,25k | 6,08k | Sale to Issuer | 0,59 | 216,56k | -4,52% |
| 2025-10-01 | Mr. Devin BlassCTO and Senior VP of Chemistry, Manufacturing & Controls | -7,61k | 5,65k | Sale to Issuer | 0,74 | 210,88k | -3,48% |
| 2025-10-01 | Ms. Lisa A. LocklearCFO, Exec. VP & Treasurer | -11,88k | 8,82k | Sale to Issuer | 0,74 | 239,08k | -4,73% |
| 2025-10-01 | Mr. Paul T. LehrGeneral Counsel & Secretary | -4,94k | 3,67k | Sale to Issuer | 0,74 | 351,13k | -1,39% |
| 2025-10-01 | Dr. Nataliya AgafonovaChief Medical Officer | -11,88k | 8,82k | Sale to Issuer | 0,74 | 226,81k | -4,98% |
| 2025-10-01 | Mr. Than PowellInsider | -2,39k | 1,77k | Sale to Issuer | 0,74 | 128,06k | -1,83% |
| 2025-08-11 | Ms. Lisa A. LocklearCFO, Exec. VP & Treasurer | 11,77k | 0,00 | Kauf | - | 250,96k | 4,92% |
| 2025-08-11 | Ms. Lisa A. LocklearCFO, Exec. VP & Treasurer | 29,42k | 0,00 | Open Market Derivative Acquisition | 0,85 | 29,42k | - |
| 2025-08-11 | Mr. Khoso BaluchInsider | 11,77k | 0,00 | Kauf | - | 52,52k | 28,87% |
| 2025-08-11 | Mr. Khoso BaluchInsider | 29,42k | 0,00 | Open Market Derivative Acquisition | 0,85 | 29,42k | - |
| 2025-07-01 | Mr. Paul T. LehrGeneral Counsel & Secretary | -1,56k | 2,00k | Sale to Issuer | 1,28 | 254,07k | -0,61% |
| 2025-07-01 | Mr. Mohamed Wa'el Ahmed HashadInsider | -13,15k | 16,83k | Sale to Issuer | 1,28 | 240,90k | -5,17% |
| 2025-07-01 | Dr. Nataliya AgafonovaChief Medical Officer | -7,43k | 9,51k | Sale to Issuer | 1,28 | 136,70k | -5,16% |
| 2025-07-01 | Mr. Devin BlassCTO and Senior VP of Chemistry, Manufacturing & Controls | -4,60k | 5,89k | Sale to Issuer | 1,28 | 116,49k | -3,80% |
| 2025-07-01 | Ms. Lisa A. LocklearCFO, Exec. VP & Treasurer | -7,43k | 9,51k | Sale to Issuer | 1,28 | 137,20k | -5,14% |
| 2025-06-23 | Mr. Paul T. LehrGeneral Counsel & Secretary | -64,16k | 73,78k | Sale to Issuer | 1,15 | 255,64k | -20,06% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
